Market Cap 160.03M
Revenue (ttm) 194.06M
Net Income (ttm) 14.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 7.39%
Debt to Equity Ratio 0.00
Volume 658,100
Avg Vol 1,012,750
Day's Range N/A - N/A
Shares Out 48.20M
Stochastic %K 38%
Beta 2.02
Analysts Strong Sell
Price Target $8.50

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services
Sector: Healthcare
Phone: 866 351 5907
Website: lifemd.com
Address:
236 Fifth Avenue, Suite 400, New York, United States
ClarissaLove
ClarissaLove Aug. 19 at 12:54 PM
$LFMD what happened to the guy that said this would never hit the 3s again, he’s been gone for nearly a month 😂😂🤭
0 · Reply
volki19
volki19 Aug. 19 at 4:59 AM
$LFMD Institutions increased their positions meaningfully from the latest 13Fs in August. Of course the data reflects the positions before the earnings. Nonetheless this looks positive and buyers outnumberd the sellers.
0 · Reply
rolypoly101
rolypoly101 Aug. 17 at 2:42 PM
$LFMD LifeMD got screwed by Novo despite them playing by the book. The profit difference between compounded and branded is massive and LifeMD switched soon as they were supposed to, which not only lost them on pricing competitiveness, they also took over a year to recover. If LifeMD simply continued the same way HIMS did, they would be doing far better financially. It's not really management being incompetent, it's because management decided to play it straight, that they are struggling but as you can see, even HIMS is losing money now that they switched to branded. Q4 ER will be the biggest one for them and according to them, when they will finally turn this around.
3 · Reply
ClarissaLove
ClarissaLove Aug. 13 at 10:29 PM
$LFMD They should have sold the telehealth business and kept WorkSimpli.
1 · Reply
ryguy69
ryguy69 Aug. 13 at 2:19 PM
$LFMD depending on the model, this trades at a 20-80% discount. Margin of safety and upside in 2027 once peptides start to show in the numbers
0 · Reply
deloris41
deloris41 Aug. 12 at 8:05 PM
$LFMD I don’t understand why investors keep trusting this company. They aren’t truthful and haven’t improved in years. file:///var/mobile/Library/SMS/Attachments/61/01/2872EFFA-AA43-4C10-A2AF-DBBFC693539E/LifeMD,%20a%20popular%20telehealth%20firm,%20put%20...ts%20over%20patient%20safety,%20ex-workers%20say.pdf
0 · Reply
TaoistTrader
TaoistTrader Aug. 12 at 3:15 PM
0 · Reply
ClarissaLove
ClarissaLove Aug. 10 at 10:35 AM
$LFMD Was anyone around in 2022/2023 when they lowered guidance like three times in one year and STILL misssd it by a big margin ? And people still have faith in this company. According to Marc the company was supposed to be EPS positive like 2 years ago. It boggles my mind that some investors still trust these people. And I’m not saying they are crooked/liars, just extremely incompetent.
2 · Reply
ClarissaLove
ClarissaLove Aug. 7 at 12:37 PM
1 · Reply
thejman1
thejman1 Aug. 6 at 9:29 PM
$LFMD no reason to not be unprofitable this quarter. they have pharma in 50 states. all the new programs have been rolled out. they spent all the money into a big negative 1st quarter. obviously the ceo doesnt know his market. and the cfo last year selling at a pumped up high of almost 16 before the big crash. and right before he was leaving. also the ceo selling stock monthly up to right before the crash. all suspicious. they keep saying next year after next year. it never goes up. they just keep diluting shares and spending cash with nothing to show for it. the only thing profitable, which was also a scam, was work simpli. all that money will be gone soon. even this company has tons of negative reviews with predatory subscriptions and tons of people unhappy. Justin keeps talking about what great care. I dont see it. gaslighting at best.
0 · Reply
Latest News on LFMD
LifeMD price target lowered to $5 from $8 at KeyBanc

2026-08-07T17:50:34.000Z - 11 days ago

LifeMD price target lowered to $5 from $8 at KeyBanc


LifeMD price target lowered to $9 from $10 at H.C. Wainwright

2026-08-07T10:26:36.000Z - 12 days ago

LifeMD price target lowered to $9 from $10 at H.C. Wainwright


LifeMD price target lowered to $8 from $10 at B. Riley

2026-08-06T13:45:43.000Z - 13 days ago

LifeMD price target lowered to $8 from $10 at B. Riley


LifeMD price target lowered to $5 from $8 at Lake Street

2026-08-06T13:16:23.000Z - 13 days ago

LifeMD price target lowered to $5 from $8 at Lake Street


LifeMD price target lowered to $7 from $8 at Mizuho

2026-08-06T11:23:24.000Z - 13 days ago

LifeMD price target lowered to $7 from $8 at Mizuho


LifeMD price target lowered to $9 from $10 at BTIG

2026-08-06T10:01:04.000Z - 13 days ago

LifeMD price target lowered to $9 from $10 at BTIG


UPDATE - LifeMD Reports Second Quarter 2026 Results

Aug 5, 2026, 7:45 PM EDT - 13 days ago

UPDATE - LifeMD Reports Second Quarter 2026 Results

LFMDP


LifeMD sees Q3 revenue $48M-$51M, consensus $58.55M

2026-08-05T22:05:37.000Z - 13 days ago

LifeMD sees Q3 revenue $48M-$51M, consensus $58.55M


LifeMD reports Q2 EPS (16c), consensus (5c)

2026-08-05T22:00:38.000Z - 13 days ago

LifeMD reports Q2 EPS (16c), consensus (5c)


LifeMD Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

LifeMD Earnings Call Transcript: Q2 2026


LifeMD Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

LifeMD Earnings release: Q2 2026


LifeMD Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

LifeMD Slides: Q2 2026


LifeMD Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

LifeMD Quarterly report: Q2 2026


LifeMD appoints Umesh Sripad as chief technology officer

2026-06-01T14:34:47.000Z - 2 months ago

LifeMD appoints Umesh Sripad as chief technology officer


LifeMD Appoints Umesh Sripad as Chief Technology Officer

Jun 1, 2026, 8:05 AM EDT - 2 months ago

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LFMDP


LifeMD Transcript: 16th Annual LD Micro Invitational Conference

May 19, 2026, 12:00 PM EDT - 3 months ago

LifeMD Transcript: 16th Annual LD Micro Invitational Conference


LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026, 8:00 AM EDT - 3 months ago

LifeMD to Participate in Upcoming Investor Conferences

LFMDP


LifeMD Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

LifeMD Slides: Investor presentation


LifeMD reports Q1 EPS (20c), consensus (12c)

2026-05-07T00:47:06.000Z - 3 months ago

LifeMD reports Q1 EPS (20c), consensus (12c)


LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M

2026-05-07T00:46:21.000Z - 3 months ago

LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M


LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M

2026-05-07T00:45:57.000Z - 3 months ago

LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M


LifeMD Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings Call Transcript: Q1 2026


LifeMD Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings release: Q1 2026


LifeMD Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Slides: Q1 2026


LifeMD Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Quarterly report: Q1 2026


LifeMD Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 3 months ago

LifeMD Reports First Quarter 2026 Results


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

LifeMD Proxy statement: Proxy filing


LifeMD management to meet with BTIG

2026-04-24T17:05:27.000Z - 4 months ago

LifeMD management to meet with BTIG


LifeMD now offering Foundayo from Eli Lilly

2026-04-10T12:26:19.000Z - 4 months ago

LifeMD now offering Foundayo from Eli Lilly

LLY


LifeMD announces launch of Wegovy subscription program

2026-03-31T14:25:15.000Z - 5 months ago

LifeMD announces launch of Wegovy subscription program

NVO


LifeMD management to meet virtually with B. Riley

2026-03-17T15:41:34.000Z - 5 months ago

LifeMD management to meet virtually with B. Riley


LifeMD upgraded to Outperform from Neutral at Mizuho

2026-03-16T08:40:05.000Z - 5 months ago

LifeMD upgraded to Outperform from Neutral at Mizuho


LifeMD Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Earnings Call Transcript: Q4 2025


LifeMD Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Annual report: Q4 2025


LifeMD Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Earnings release: Q4 2025


LifeMD Slides: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Slides: Q4 2025


LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mar 9, 2026, 4:05 PM EDT - 5 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMDP


LifeMD Earnings Call Transcript: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Earnings Call Transcript: Q3 2025


LifeMD Quarterly report: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Quarterly report: Q3 2025


LifeMD Earnings release: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Earnings release: Q3 2025


LifeMD Slides: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Slides: Q3 2025


LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 9 months ago

LifeMD Reports Third Quarter 2025 Results

LFMDP


LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 10 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMDP


ClarissaLove
ClarissaLove Aug. 19 at 12:54 PM
$LFMD what happened to the guy that said this would never hit the 3s again, he’s been gone for nearly a month 😂😂🤭
0 · Reply
volki19
volki19 Aug. 19 at 4:59 AM
$LFMD Institutions increased their positions meaningfully from the latest 13Fs in August. Of course the data reflects the positions before the earnings. Nonetheless this looks positive and buyers outnumberd the sellers.
0 · Reply
rolypoly101
rolypoly101 Aug. 17 at 2:42 PM
$LFMD LifeMD got screwed by Novo despite them playing by the book. The profit difference between compounded and branded is massive and LifeMD switched soon as they were supposed to, which not only lost them on pricing competitiveness, they also took over a year to recover. If LifeMD simply continued the same way HIMS did, they would be doing far better financially. It's not really management being incompetent, it's because management decided to play it straight, that they are struggling but as you can see, even HIMS is losing money now that they switched to branded. Q4 ER will be the biggest one for them and according to them, when they will finally turn this around.
3 · Reply
ClarissaLove
ClarissaLove Aug. 13 at 10:29 PM
$LFMD They should have sold the telehealth business and kept WorkSimpli.
1 · Reply
ryguy69
ryguy69 Aug. 13 at 2:19 PM
$LFMD depending on the model, this trades at a 20-80% discount. Margin of safety and upside in 2027 once peptides start to show in the numbers
0 · Reply
deloris41
deloris41 Aug. 12 at 8:05 PM
$LFMD I don’t understand why investors keep trusting this company. They aren’t truthful and haven’t improved in years. file:///var/mobile/Library/SMS/Attachments/61/01/2872EFFA-AA43-4C10-A2AF-DBBFC693539E/LifeMD,%20a%20popular%20telehealth%20firm,%20put%20...ts%20over%20patient%20safety,%20ex-workers%20say.pdf
0 · Reply
TaoistTrader
TaoistTrader Aug. 12 at 3:15 PM
0 · Reply
ClarissaLove
ClarissaLove Aug. 10 at 10:35 AM
$LFMD Was anyone around in 2022/2023 when they lowered guidance like three times in one year and STILL misssd it by a big margin ? And people still have faith in this company. According to Marc the company was supposed to be EPS positive like 2 years ago. It boggles my mind that some investors still trust these people. And I’m not saying they are crooked/liars, just extremely incompetent.
2 · Reply
ClarissaLove
ClarissaLove Aug. 7 at 12:37 PM
1 · Reply
thejman1
thejman1 Aug. 6 at 9:29 PM
$LFMD no reason to not be unprofitable this quarter. they have pharma in 50 states. all the new programs have been rolled out. they spent all the money into a big negative 1st quarter. obviously the ceo doesnt know his market. and the cfo last year selling at a pumped up high of almost 16 before the big crash. and right before he was leaving. also the ceo selling stock monthly up to right before the crash. all suspicious. they keep saying next year after next year. it never goes up. they just keep diluting shares and spending cash with nothing to show for it. the only thing profitable, which was also a scam, was work simpli. all that money will be gone soon. even this company has tons of negative reviews with predatory subscriptions and tons of people unhappy. Justin keeps talking about what great care. I dont see it. gaslighting at best.
0 · Reply
rolypoly101
rolypoly101 Aug. 6 at 7:13 PM
$LFMD The worst is over and you're all selling at the bottom. They've been guiding this path, even if it's a little worse than what they projected, it also means Q4+ will be profitable.
0 · Reply
gforce77
gforce77 Aug. 6 at 5:50 PM
$LFMD knew it got to be too cheap, this is not a $3 stock, grab it when it has a bad quarter, it has gone to 10-12 many times for those long term owners here
1 · Reply
TaoistTrader
TaoistTrader Aug. 6 at 3:57 PM
$LFMD all out. That wasn’t a good report
0 · Reply
ClarissaLove
ClarissaLove Aug. 6 at 1:57 PM
$LFMD This has much further to drop…..
0 · Reply
gforce77
gforce77 Aug. 6 at 1:50 PM
$LFMD just increased my position at 3.19, like the price point a lot for risk/reward here.
0 · Reply
ClarissaLove
ClarissaLove Aug. 6 at 12:56 PM
$LFMD Burning obscene amounts of cash, declining revenue, declining subscriber numbers. Shouldn’t revenue be booming right now?
1 · Reply
Leroy_Jankins
Leroy_Jankins Aug. 6 at 12:10 PM
$LFMD Alex1965 blocked me so i can’t see how he is framing this ER positively. Can someone screenshot and share?
1 · Reply
SocialYoutube
SocialYoutube Aug. 6 at 12:52 AM
$HIMS $LFMD touting 89% gross margins is like peacocking a luxury rental car. 1. Lost subscribers this quarter. 2. Reported less telehealth revenue YOY 3. Only have 25 million in cash left. 5 of which must remain in the bank as part of a debt covenant. 4. Revised down both their yearly revenue and EBITDA
1 · Reply
xbizo
xbizo Aug. 5 at 9:55 PM
$LFMD The Company’s fourth quarter 2026 guidance of $60 million revenue increased to $64 million and $3 million to $6 million of adjusted EBITDA implies an annualized exit run rate of approximately $250 million of revenue and $22 million EBITDA
0 · Reply
Leroy_Jankins
Leroy_Jankins Aug. 5 at 9:24 PM
$LFMD when is the last time management actually best guidance?
0 · Reply
thejman1
thejman1 Aug. 5 at 8:39 PM
$LFMD going this way, the end of the year all the money from work simpli will be gone.
0 · Reply
StockPitcher
StockPitcher Aug. 5 at 8:32 PM
$LFMD Man this is crushing. I have done a 180 on this thing. I would be happy to get out at breakeven. Probably going to look to sell covered calls aggressively at $4 and $5. I don’t know what is causing issues but this business model seems to be commoditized
1 · Reply